Research
Print page Print page
Switch language
Rigshospitalet - a part of Copenhagen University Hospital
Published

Influence of volumetric modulated arc therapy and FET-PET scanning on treatment outcomes for glioblastoma patients

Research output: Contribution to journalJournal articleResearchpeer-review

  1. Deformable image registration uncertainty for inter-fractional dose accumulation of lung cancer proton therapy

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Diabetes increases the risk of serious adverse events after re-irradiation of the spine

    Research output: Contribution to journalJournal articleResearchpeer-review

  1. PET imaging of meningioma with 18F-FLT: a predictor of tumour progression

    Research output: Contribution to journalJournal articleResearchpeer-review

  2. Effect of blood glucose and body weight on image quality in brain [18F]FDG PET imaging

    Research output: Contribution to journalJournal articleResearchpeer-review

  3. Mania triggered by levodopa treatment in a patient with frontotemporal dementia caused by A C9orf72 repeat expansion: A case report

    Research output: Contribution to journalJournal articleResearchpeer-review

  4. Pharmacokinetic analysis of [68Ga]Ga-DOTA-TOC PET in meningiomas for assessment of in vivo somatostatin receptor subtype 2

    Research output: Contribution to journalJournal articleResearchpeer-review

  5. Validation of diffuse correlation spectroscopy against 15O-water PET for regional cerebral blood flow measurement in neonatal piglets

    Research output: Contribution to journalJournal articleResearchpeer-review

View graph of relations

BACKGROUND: We sought to assess the influence of the clinical introduction of new radiotherapy technologies on glioblastoma patients' outcomes.

METHODS: Newly diagnosed glioblastoma patients treated with 60 Gy and temozolomide (2005-2014) were analyzed. The patients' GTV and CTV were defined based on MR (n = 521) or FET-PET/MR (n = 190), and were treated using conformal radiotherapy (CRT, n = 159) or image-guided volumetric modulated arc therapy with hippocampal sparing (IG-VMAT, n = 362). Progression-free survival (PFS) was assessed using the McDonald criteria. Associations between clinical data, dosimetry data, treatment technology, for PFS and overall survival (OS) were explored.

RESULTS: The PFS (7 months) and OS (15 months) were unaffected by CRT, IG-VMAT and FET-PET technology. Mean brain dose was correlated with tumor volume, and was lower for IG-VMAT vs. CRT (p < 0.001). Larger mean brain dose was associated with inferior PFS (univariate/multivariate Cox models, p < 0.001) and OS (univariate, p < 0.001). Multivariate Cox models revealed association of larger mean brainstem dose (p < 0.001), BTV (p = 0.045), steroid use at baseline (p = 0.003), age (p = 0.019) and MGMT status (p = 0.022) with lower OS.

CONCLUSIONS: Introduction of hippocampal-sparing IG-VMAT technology appeared to be safe, and may have reduced toxicity and cognitive impairment. Larger mean brain dose was strongly associated with inferior PFS and OS.

Original languageEnglish
JournalRadiotherapy and oncology : journal of the European Society for Therapeutic Radiology and Oncology
Volume130
Pages (from-to)149-155
Number of pages7
ISSN0167-8140
DOIs
Publication statusPublished - 2019

    Research areas

  • FET-PET, Glioblastoma, IGRT, Radiotherapy, Technology, VMAT, Brain Neoplasms/diagnostic imaging, Radiotherapy, Intensity-Modulated/methods, Humans, Middle Aged, Proportional Hazards Models, Treatment Outcome, Tumor Burden, Glioblastoma/diagnostic imaging, Tyrosine/analogs & derivatives, Adult, Positron-Emission Tomography/methods

ID: 56319972